Study confirming dupilumab’s link to cancer tops most-read dermatitis articles of 2024

Key takeaways:

• A study finding an association between dupilumab treatment for atopic dermatitis and a risk for cutaneous T-cell lymphoma topped the list.
• Content involving many other dermatitis treatments followed.

The popular atopic dermatitis drug dupilumab has been found to be associated with an increased risk for cutaneous T-cell lymphoma in treated patients. It was the top dermatitis article in dermatology this year.

Other top dermatitis stories included meeting coverage showing that some atopic dermatitis treatments may be just as harmful as they are helpful as well as a study tracing a link between antihypertensive medications and eczematous dermatitis in older patients.

Read these and more top dermatitis articles of 2024 below:

Dupilumab treatment for atopic dermatitis linked to cutaneous T-cell lymphoma development

A new study found that dupilumab is associated with an increased risk for cutaneous T-cell lymphoma in patients taking the drug for AD. Read more.

AD treatments with greatest efficacy may also cause most harm

According to a presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting, the most effective treatments for AD, such as high-dose upadacitinib, may also cause the most harm by increasing adverse events. Read more.

Antihypertensive medications associated with eczematous dermatitis in older patients

Due to a small increase in eczematous dermatitis, older adults taking antihypertensive drugs should be monitored and this possibility considered when assessing for eczema based on a study’s findings. Read more.

JAK inhibitors have ‘untapped potential’ in treatment of inflammatory skin diseases

According to a speaker at South Beach Symposium, Janus kinase inhibitors have a unique mechanism of action, giving them the potential to push the boundaries of efficacy in the treatment of inflammatory skin diseases, especially AD. Read more.

AD in children may be linked to metabolic syndrome, liver disease

A study found that AD in children may be associated with metabolic syndrome and nonalcoholic fatty liver disease. Read more.

AD may be linked to inflammatory bowel disease

The punches keep on coming for patients with AD as another study found the condition may also be associated with inflammatory bowel disease, suggesting a multidisciplinary approach may be necessary. Read more.

Higher dietary sodium intake associated with increased risk for AD

A sodium-restricting diet may be helpful for the management of AD as a study found that higher dietary sodium intake was associated with a higher risk for current AD. Read more.

Most patients with chronic hand eczema suffer from corticosteroid phobia

The majority of patients with chronic hand eczema suffer from corticosteroid phobia, which negatively impacted treatment adherence. Read more.

Beneath the Surface: Exploring sodium’s effect on dermatologic disease

In this edition of Beneath the Surface, a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts, Katrina Abuabara, MD, MA, MSCE, associate professor of dermatology at University of California, San Francisco, discussed details on her study linking higher sodium intake to an increased risk for AD. Watch here.

Yeast and Zoryve: New findings provide better understanding of seborrheic dermatitis

In this article, dermatologist Raj Chovatiya, MD, PhD, MSCI, spoke to Healio about his new findings in seborrheic dermatitis and how to best treat diverse patient groups with this condition. Read more.